Unknown

Dataset Information

0

Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19.


ABSTRACT: SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort to identify therapeutic solutions, there is a critical need for improvement in the prognosis of COVID-19. Here, we report plasma proteome fingerprinting that predict high (hospitalized) and low-risk (outpatients) cases of COVID-19 identified by a platform that combines machine learning with matrix-assisted laser desorption ionization mass spectrometry analysis. Sample preparation, MS, and data analysis parameters were optimized to achieve an overall accuracy of 92%, sensitivity of 93%, and specificity of 92% in dataset without feature selection. We identified two distinct regions in the MALDI-TOF profile belonging to the same proteoforms. A combination of SDS-PAGE and quantitative bottom-up proteomic analysis allowed the identification of intact and truncated forms of serum amyloid A-1 and A-2 proteins, both already described as biomarkers for viral infections in the acute phase. Unbiased discrimination of high- and low-risk COVID-19 patients using a technology that is currently in clinical use may have a prompt application in the noninvasive prognosis of COVID-19. Further validation will consolidate its clinical utility.

SUBMITTER: Lazari LC 

PROVIDER: S-EPMC8321665 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-06-22 | PXD025138 | Pride
2021-06-22 | PXD021581 | Pride
| S-EPMC4220686 | biostudies-literature
| S-EPMC6264847 | biostudies-literature
| S-EPMC3592410 | biostudies-literature
| S-EPMC9305670 | biostudies-literature
| S-EPMC6296472 | biostudies-literature
| S-EPMC3818176 | biostudies-literature
| S-EPMC3615692 | biostudies-literature
| S-EPMC7147288 | biostudies-literature